aNational Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China bDepartment of Hematology, Nanfang ...

Kali Linux 2026.2, the second release of the year, is now available for download, featuring 9 new tools and numerous Kali ...

The changes to Army fitness testing have been constant and confusing, even to soldiers, over the past decade. The first ...

Jasneet Singh is a writer who finally has a platform to indulge in long rants about small moments on TV and film in overwhelming detail. With a literature background, she is drawn to the narrative ...

GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. Are you curious about where you need to go first in Subnautica 2?

William Parks is a Game Rant editor who specializes in puzzle games, indie releases, Nintendo titles, and completion-focused guide coverage. Since joining Game Rant in 2019, he has written and edited ...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced positive interim Phase 3 results from the SUCCESSOR-2 study (NCT05552976). In the trial, oral mezigdomide in ...

Mezigdomide (a CELMoD) combined with carfilzomib/dexamethasone met the phase 3 primary end point, delivering statistically significant, clinically meaningful PFS ...

The FDA plans to drop its long-standing requirement that drugmakers conduct two rigorous studies to secure approval for new drugs and is also pushing to expand over-the-counter access to medications.

(UroToday.com) The 2024 American Society of Clinical Oncology (ASCO) annual meeting featured a session on prostate cancer, and a presentation by Dr. Daniel Petrylak discussing initial results of a ...

Discover What’s Streaming On: All aboard the Hijack Season 2 train! Three years ago, Apple TV‘s high-octane thriller captivated viewers as Idris Elba’s Sam Nelson used his expert negotiating skills to ...

CD40 agonist mitazalimab + mFOLFIRINOX (mFFX) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): Final efficacy analysis of the OPTIMIZE-1 study. This is an ASCO Meeting Abstract ...